Ifp Advisors, Inc Lineage Cell Therapeutics, Inc. Transaction History

Ifp Advisors, Inc

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Sep 06, 2022	BUY	$1.12 - $1.61 $8 - $12	8 New	8 $1,000
Q2 2022 Aug 12, 2022	SELL	$1.12 - $1.61 $8 - $12	-8 Closed	0 $0
Q1 2022 Sep 06, 2022	BUY	$1.21 - $2.48 $9 - $19	8 New	8 $0
Q4 2021 Jan 12, 2022	SELL	$1.84 - $2.68 $20,381 - $29,686	-11,077 Closed	0 $0
Q3 2021 Oct 06, 2021	BUY	$2.26 - $2.86 $18,080 - $22,880	8,000 Added 259.99%	11,077 $28,000
Q1 2021 Apr 30, 2021	BUY	$1.77 - $3.1 $3,540 - $6,200	2,000 Added 185.7%	3,077 $8,000
Q3 2019 Nov 07, 2019	BUY	$0.85 - $1.24 $915 - $1,335	1,077 New	1,077 $1,000

120

94.2M

63.8K

Ticker LCTX
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 169,755,008
Market Cap $91.7M
Description
Lineage Cell Therapeutics, Inc., a clinical-stage biotechnology company, develops novel cell therapies for the treatment of degenerative diseases in the United States and internationally. The company develops OpRegen, a retinal pigment epithelium cell replacement therapy, which is in Phase I/IIa clinical trial for the treatment of the dry age-re...

Get notified when there are updates to the investment portfolio of Ifp Advisors, Inc, based on Form 13F filings with the SEC.

Stay updated on Ifp Advisors, Inc with notifications on news.